Transcription of Section 2: Qualitative and quantitative composition
{{id}} {{{paragraph}}}
An agency of the European Union SmPC Advisory Group Section 2: Qualitative and quantitative composition Rev. 1 SmPC training presentation Note: for full information refer to the European Commission s Guideline on summary of product characteristics (SmPC) Index objectives principles Qualitative declaration quantitative declaration information Biological medicinal products Herbal medicinal products * Section 2: Qualitative and quantitative composition 2 I. General objectives of Section 2 Section 2: Qualitative and quantitative composition 3 Excipients listed in the Annex to the Guideline on the excipients in the label and package leaflet of medicinal product for human use should be stated here under a separate subheading qualitatively, and, quantitatively This Section should provide full
I. General objectives of section 2 3 Section 2: Qualitative and quantitative composition Excipients listed in the Annex to the “Guideline on the excipients in the label and package leaflet of medicinal product for human use”
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Emergency Neurological Life Support Status, Guide for Drug Level Monitoring of Commonly, Chemotherapy for Resected Pancreatic AdenocarcinomaUsing Capecitabine and Gemcitabine, For the Patient Capecitabine, CYP3A4, Be Infused Through A Central Line, Drug Shortage information Action Plan, Neecham Confusion Tool